Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Rohto-Mentholatum Thailand is a prominent subsidiary of the Japanese healthcare giant Rohto Pharmaceutical, specializing in the marketing and distribution of consumer healthcare and skincare products. Established in 1996, the company has become a market leader in Thailand for various categories, including lip care, sun protection, and specialized skincare under brands such as Hada Labo, Mentholatum, and Acnes. Their portfolio includes over-the-counter (OTC) medications like eye drops and topical analgesics, as well as functional cosmetics. Rohto-Mentholatum Thailand focuses on delivering innovative wellness solutions through high-quality formulations backed by Japanese research and development. The company plays a strategic role in the parent group's expansion within the Southeast Asian consumer health sector.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Rohto-Mentholatum Thailand.